carvedilol has been researched along with Chronic Liver Failure in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Propranolol has been used as prophylaxis for variceal bleeding in patients with cirrhosis." | 6.82 | A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis. ( Baik, SK; Jang, JY; Jeong, SW; Kim, DJ; Kim, MY; Kim, SG; Kim, TY; Kim, YS; Lee, B; Seo, YS; Sohn, JH; Suk, KT; Um, SH, 2016) |
"Ivabradine combined with carvedilol improves LVDD, achieves THR more often and reduces risk of encephalopathy, acute kidney injury with improved survival in patients with cirrhosis." | 2.94 | Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis. ( Goyal, R; Khumuckham, JS; Kumar, G; Premkumar, M; Rangegowda, D; Sarin, SK; Shasthry, SM; Thomas, SS; Vyas, T, 2020) |
"Propranolol has been used as prophylaxis for variceal bleeding in patients with cirrhosis." | 2.82 | A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis. ( Baik, SK; Jang, JY; Jeong, SW; Kim, DJ; Kim, MY; Kim, SG; Kim, TY; Kim, YS; Lee, B; Seo, YS; Sohn, JH; Suk, KT; Um, SH, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Premkumar, M | 1 |
Rangegowda, D | 1 |
Vyas, T | 1 |
Khumuckham, JS | 1 |
Shasthry, SM | 1 |
Thomas, SS | 1 |
Goyal, R | 1 |
Kumar, G | 1 |
Sarin, SK | 1 |
Kim, SG | 1 |
Kim, TY | 1 |
Sohn, JH | 1 |
Um, SH | 1 |
Seo, YS | 1 |
Baik, SK | 1 |
Kim, MY | 1 |
Jang, JY | 1 |
Jeong, SW | 1 |
Lee, B | 1 |
Kim, YS | 1 |
Suk, KT | 1 |
Kim, DJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Efficacy of Carvedilol + Ivabradine vs Carvedilol Alone for Left Ventricular Diastolic Dysfunction in Chronic Liver Disease Patients and Its' Impact on Morbidity and Mortality; a Prospective Randomized Controlled Trial.[NCT04111133] | 130 participants (Anticipated) | Interventional | 2020-01-01 | Recruiting | |||
Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its' Impact on Morbidity and Mortality[NCT02294292] | 189 participants (Actual) | Interventional | 2014-07-01 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for carvedilol and Chronic Liver Failure
Article | Year |
---|---|
Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.
Topics: Carvedilol; End Stage Liver Disease; Humans; Ivabradine; Liver Cirrhosis; Severity of Illness Index | 2020 |
Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.
Topics: Carvedilol; End Stage Liver Disease; Humans; Ivabradine; Liver Cirrhosis; Severity of Illness Index | 2020 |
Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.
Topics: Carvedilol; End Stage Liver Disease; Humans; Ivabradine; Liver Cirrhosis; Severity of Illness Index | 2020 |
Carvedilol Combined With Ivabradine Improves Left Ventricular Diastolic Dysfunction, Clinical Progression, and Survival in Cirrhosis.
Topics: Carvedilol; End Stage Liver Disease; Humans; Ivabradine; Liver Cirrhosis; Severity of Illness Index | 2020 |
A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
Topics: Adult; Antihypertensive Agents; Ascites; Carbazoles; Carvedilol; End Stage Liver Disease; Esophageal | 2016 |